Princeton University Professor Uwe Reinhardt does not believe that it is possible to keep per person health care costs from rising from twice the average in the countries with longer life expectancies than the United States to more than four times the average in countries with longer life expectancies. Of course there are obvious ways to get costs done, such as the $270 billion a year that could be saved by eliminating government patent monopolies for prescription drugs and adopting a more efficient mechanism for financing drug research.
But the easiest mechanism to eliminate these enormous price differentials would be to simply open the market to international trade and allow people in the United States to take advantage of the more efficient health care systems in other countries. Too bad the NYT's economists don't believe in free trade.
"The CEPR website currently takes longer to load than usual. We hope to have this and other issues addressed shortly. While this much needed site maintenance is taking place, our content is still available so please continue to slooowwwly surf the pages of our site. Thank you for your patience."